businessNewsغير مصنف

Merck, Bristol-Myers profits rise on cancer drug sales

Merck & Co Inc and Bristol-Myers Squibb Co posted better-than-expected third quarter profit and raised their 2018 earnings forecasts on Thursday due to strong demand for their rival cancer immuno-oncology treatments.

اظهر المزيد

مقالات ذات صلة

زر الذهاب إلى الأعلى